For information on Philips consumer products or consumer product support in light of COVID-19, please click here.
The V60 Plus gives care providers flexibility to address a wide variety of respiratory needs efficiently. The device has the capability to provide noninvasive ventilation (NIV), invasive mechanical ventilation (IMV) and high flow therapy (HFT) care.
Trilogy EV300 is a versatile ventilator that can support treatment in varying care spaces within the hospital - from the emergency department to the ICU. Additionally, Trilogy EV300 is part of the Trilogy Evo platform of ventilators, the only life-support ventilator platform designed to stay with patients and provide consistent therapy and monitoring as their conditions and care environments change.
This Philips-sponsored webinar is now available ON-DEMAND. Viewers will learn successful NIV strategies used to treat severe COVID-19 patients, with a focus on Philips NIV solutions used to provide ventilation support.
References
1 Philips V60 Plus ventilator software upgrade is provided in the US under an FDA emergency use policya, which authorizes its use for the duration of the COVID-19 public health emergency declaration, after which the software upgrade may no longer be used. This device is not FDA cleared or approved.
a Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, issued March 2020
